| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5556702 | Life Sciences | 2017 | 8 Pages |
Abstract
For the first time, by this study, we found evidence that BPH-1 cell proliferation could be inhibited with EGCG through the disruption of cytoskeleton organization and ECM interactions. Consequently, EGCG might be useful in the prevention and treatment of diseases characterized by excessive cell proliferation such as BPH.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Burcu Erbaykent Tepedelen, Elif Soya, Mehmet Korkmaz,